• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pregnancy in a liver transplant patient treated with everolimus and tacrolimus.

作者信息

Ciortea Razvan, Ciobanu Lidia, Matei Emil, Zanfi Chiara, Blaga Ligia Daniela

机构信息

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj- Napoca; 2 nd Obstetrics and Gynecology Department, County Hospital, Cluj-Napoca, Romania. .

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj- Napoca, Romania; Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania. .

出版信息

J Gastrointestin Liver Dis. 2020 Dec 13;29(4):685-686. doi: 10.15403/jgld-3181.

DOI:10.15403/jgld-3181
PMID:33331336
Abstract
摘要

相似文献

1
Pregnancy in a liver transplant patient treated with everolimus and tacrolimus.一名接受依维莫司和他克莫司治疗的肝移植患者怀孕了。
J Gastrointestin Liver Dis. 2020 Dec 13;29(4):685-686. doi: 10.15403/jgld-3181.
2
Spontaneous Hepatitis C Virus Clearance in a Liver Transplant Recipient After Conversion From Tacrolimus to Everolimus.他克莫司转换为依维莫司后肝移植受者丙型肝炎病毒的自发清除
Exp Clin Transplant. 2022 Sep;20(9):883-884. doi: 10.6002/ect.2022.0168.
3
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.新诊断肝移植患者接受依维莫司联合低剂量他克莫司治疗的 3 年结局：一项随机、多中心研究的随访结果。
Transplantation. 2015 Jul;99(7):1455-62. doi: 10.1097/TP.0000000000000555.
4
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years.肝移植后早期从他克莫司转换为依维莫司：2 年的结果。
Liver Transpl. 2019 Dec;25(12):1822-1832. doi: 10.1002/lt.25664.
5
Everolimus: a guide to its use in liver transplantation.依维莫司：在肝移植中的应用指南。
BioDrugs. 2013 Aug;27(4):407-11. doi: 10.1007/s40259-013-0041-6.
6
Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics.成人肝移植患者依维莫司的群体药代动力学：与他克莫司处置的比较和儿科外推。
Clin Transl Sci. 2022 Nov;15(11):2652-2662. doi: 10.1111/cts.13389. Epub 2022 Sep 14.
7
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.评估在初发肝移植受者中早期开始使用依维莫司促进他克莫司减量时肾功能的疗效、安全性及演变：一项随机对照试验的研究方案
Trials. 2015 Mar 26;16:118. doi: 10.1186/s13063-015-0626-0.
8
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.一项开放性、随机试验表明，依维莫司联合他克莫司或环孢素与标准免疫抑制方案在肾移植初治患者中的疗效相当。
Kidney Int. 2019 Jul;96(1):231-244. doi: 10.1016/j.kint.2019.01.041. Epub 2019 Feb 27.
9
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.肝移植术后2年，依维莫司比他克莫司导致的体重增加更少：一项随机多中心研究的结果
Transplantation. 2017 Dec;101(12):2873-2882. doi: 10.1097/TP.0000000000001913.
10
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials.依维莫司联合低剂量他克莫司治疗肝移植受者的疗效和安全性：2 项随机对照试验的汇总分析 24 个月结果。
Transplantation. 2021 Jul 1;105(7):1564-1575. doi: 10.1097/TP.0000000000003394.

引用本文的文献

1
Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.女性器官移植受者所生的胎儿和哺乳期免疫抑制暴露儿童的结局。
Paediatr Drugs. 2022 Sep;24(5):483-497. doi: 10.1007/s40272-022-00525-y. Epub 2022 Jul 23.